Search - tctmd.com

Displaying 841 - 860 of 1082

Sort: Relevancy | Date

News Daily News

PARTNER: 外科手术与TAVR相比, 出血情况更普遍、更危险

Yael L. Maxwell

January 01, 2014

News Daily News

PARTNER: Hemorragias Más Prevalentes y Peligrosas con la Cirugía que con la TAVR

Yael L. Maxwell

January 01, 2014

News Daily News

PARTNER: Bleeding More Prevalent, Dangerous with Surgery vs. TAVR

Yael L. Maxwell

January 01, 2014

News Daily News

Los Resultados Iniciales TAVR son Equiparables a los Resultados PARTNER, aunque con Menos Complicaciones

Jason Kahn

January 01, 2014

News Daily News

La Anemia, Presente en Más de la Mitad de los Pacientes TAVR, condiciona una Mortalidad a Largo Plazo

Jason Kahn

January 01, 2014

News Daily News

Early TAVR Results Match PARTNER Outcomes, But With Fewer Complications

Jason Kahn

January 01, 2014

News Daily News

Anemia Present in More than Half of TAVR Patients, Raises Long-term Mortality

Jason Kahn

January 01, 2014

News Industry News

Endurant II AAA Stent Graft from Medtronic Delivers Durable, Consistent and Proven Outcomes in Real-World Setting

November 24, 2013

News Conference News AHA 2013

Registry Study Summarizes Initial US Experience with First Approved TAVR Device

Jason Kahn

November 16, 2013

News Industry News

Volcano Announces Final Results of ADVISE II Registry, Prospectively Demonstrating Performance and Utility of iFR® Modality[1] to Measure and Document Severity of Intermediate Coronary Blockages

October 30, 2013

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

News Conference News TCT 2013

Need, Potential Exist for Global Integrated Regulatory Approach in Cardiology

October 30, 2013

News Conference News TCT 2013

Opportunities Exist to Improve Outcomes in Transapical TAVR

October 29, 2013

News Conference News TCT 2013

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

October 29, 2013

News Conference News TCT 2013

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

October 28, 2013

News Industry News

Philips and RealView Imaging conclude world’s first study to evaluate live 3D holographic imaging in interventional cardiology

October 28, 2013

News Industry News

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

October 28, 2013

News Daily News

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

October 25, 2013

News Daily News

PARTNER: La Enfermedad Pulmonar No es Barrera para la TAVR pero Aumenta el Riesgo de Mortalidad

October 25, 2013

Advertisement

PARTNER: 外科手术与TAVR相比, 出血情况更普遍、更危险

PARTNER: Hemorragias Más Prevalentes y Peligrosas con la Cirugía que con la TAVR

PARTNER: Bleeding More Prevalent, Dangerous with Surgery vs. TAVR

Los Resultados Iniciales TAVR son Equiparables a los Resultados PARTNER, aunque con Menos Complicaciones

La Anemia, Presente en Más de la Mitad de los Pacientes TAVR, condiciona una Mortalidad a Largo Plazo

Early TAVR Results Match PARTNER Outcomes, But With Fewer Complications

Anemia Present in More than Half of TAVR Patients, Raises Long-term Mortality

Endurant II AAA Stent Graft from Medtronic Delivers Durable, Consistent and Proven Outcomes in Real-World Setting

Registry Study Summarizes Initial US Experience with First Approved TAVR Device

Volcano Announces Final Results of ADVISE II Registry, Prospectively Demonstrating Performance and Utility of iFR® Modality[1] to Measure and Document Severity of Intermediate Coronary Blockages

Two Trials to Assess TAVR in Moderate-Risk Patients

Innovation in Intervention: Perspectives from Industry

Need, Potential Exist for Global Integrated Regulatory Approach in Cardiology

Opportunities Exist to Improve Outcomes in Transapical TAVR

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

Philips and RealView Imaging conclude world’s first study to evaluate live 3D holographic imaging in interventional cardiology

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

PARTNER: La Enfermedad Pulmonar No es Barrera para la TAVR pero Aumenta el Riesgo de Mortalidad

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content